BTS
GSK icon

BB&T Securities’s GSK GSK Stock Holding History

BB&T Securities’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$15.6M Sell
292,117
-2,821
-1% -$145K 0.14% 192
2019
Q2 		$14.8M Buy
294,938
+1,141
+0.4% +$57.3K 0.13% 206
2019
Q1 		$15.3M Buy
293,797
+10,123
+4% +$506K 0.15% 190
2018
Q4 		$13.5M Sell
283,674
-13,793
-5% -$679K 0.15% 183
2018
Q3 		$14.9M Buy
297,467
+537
+0.2% +$27.3K 0.15% 192
2018
Q2 		$15M Sell
296,930
-22,076
-7% -$1.11M 0.16% 177
2018
Q1 		$15.6M Buy
319,006
+102,132
+47% +$4.76M 0.18% 158
2017
Q4 		$9.62M Sell
216,874
-52,775
-20% -$2.44M 0.12% 226
2017
Q3 		$13.7M Buy
269,649
+38,951
+17% +$1.98M 0.19% 149
2017
Q2 		$12.4M Buy
230,698
+45,778
+25% +$2.44M 0.18% 158
2017
Q1 		$9.74M Sell
184,920
-67,516
-27% -$3.43M 0.13% 191
2016
Q4 		$13.5M Sell
252,436
-1,390
-0.5% -$68.7K 0.2% 129
2016
Q3 		$13.7M Sell
253,826
-14,653
-5% -$803K 0.2% 122
2016
Q2 		$14.5M Buy
268,479
+10,590
+4% +$558K 0.23% 113
2016
Q1 		$13.1M Buy
257,889
+55,890
+28% +$2.78M 0.21% 115
2015
Q4 		$10.2M Buy
201,999
+43,373
+27% +$2.21M 0.21% 107
2015
Q3 		$7.62M Sell
158,626
-78,742
-33% -$4.1M 0.17% 118
2015
Q2 		$12.4M Buy
237,368
+32,525
+16% +$1.83M 0.26% 88
2015
Q1 		$11.8M Buy
204,843
+24,976
+14% +$1.43M 0.26% 90
2014
Q4 		$9.61M Buy
179,867
+35,989
+25% +$2.01M 0.22% 98
2014
Q3 		$8.27M Buy
143,878
+14,628
+11% +$897K 0.19% 113
2014
Q2 		$8.64M Buy
129,250
+29,809
+30% +$2.02M 0.21% 100
2014
Q1 		$6.64M Buy
99,441
+6,204
+7% +$419K 0.17% 109
2013
Q4 		$6.22M Buy
93,237
+13,020
+16% +$844K 0.17% 120
2013
Q3 		$5.03M Buy
80,217
+2,859
+4% +$184K 0.16% 118
2013
Q2 		$4.83M Buy
+77,358
New +$4.91M 0.16% 118

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

BB&T Securities's GSK Position: Q3 2019 in Review

BB&T Securities reduced its GSK (GSK) stake by 0.96% in Q3 2019, selling an estimated $145K and leaving 292,117 shares worth $15.6M. The position accounts for 0.14% of the portfolio, ranked #192.

BB&T Securities first reported a position in GSK in Q2 2013 and has held it in 26 quarters since. 806 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • BB&T Securities held 292,117 shares of GSK worth $15.6M as of Q3 2019.
  • BB&T Securities sold 2,821 GSK shares in Q3 2019, an estimated $145K.
  • GSK made up 0.14% of BB&T Securities's portfolio in Q3 2019, its #192 holding.
  • BB&T Securities first reported a position in GSK in Q2 2013 and has held it in 26 quarters since.
  • 806 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.